Sofgen Pharma S.A. (PROCF)
OTCMKTS · Delayed Price · Currency is USD
0.0251
0.00 (0.00%)
Jul 24, 2026, 9:30 AM EST
Sofgen Pharma Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Revenue Revenue Growth | 373.8 | 373.8 | 423.75 | 403.2 | 403.74 | 331.47 |
Revenue Growth | -8.48% | -11.79% | 5.10% | -0.13% | 21.80% | 2.05% |
Gross Profit Gross Profit Growth | 191.48 | 191.48 | 237.98 | 235.13 | 229.6 | 191.31 |
Operating Income Operating Income Growth | -28.48 | -28.48 | 61.24 | 34.11 | -9.07 | 63.05 |
Net Income Net Income Growth | -68.3 | -68.3 | 40.34 | 36.13 | -106.99 | -10.45 |
Earnings Per Share EPS Growth | -0.68 | -0.68 | 0.40 | 0.36 | -1.09 | -0.11 |
EPS Growth | - | - | 11.79% | - | - | - |
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
CAN CAN Growth | 58.56 | 58.56 | 75.66 | 77.31 | 64.2 | 44.81 |
Procaps Colombia Procaps Colombia Growth | 139.52 | 139.52 | 148.27 | 145.28 | 156.85 | 121.53 |
CASAND CASAND Growth | 65.91 | 65.91 | 96.32 | 80.04 | 67.61 | 40.09 |
Diabetrics Diabetrics Growth | 44.57 | 44.57 | 40.1 | 34.47 | 47.62 | 39.22 |
Nextgel Nextgel Growth | 221.71 | 221.71 | 243.04 | 253.47 | 241.56 | 201.29 |
Intra-Segment Eliminations Intra-Segment Eliminations Growth | -156.46 | -156.46 | -179.65 | -187.35 | -174.1 | -117.91 |
Total Total Growth | 373.8 | 373.8 | 423.75 | 403.2 | 403.74 | 331.47 |
| Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Cash & Investments Cash & Investments Growth | 30.32 | 30.32 | 17.51 | 43 | 72.11 | 4.23 |
Total Debt Total Debt Growth | 306.77 | 306.77 | 312.65 | 300.22 | 253.37 | 454.52 |
Net Cash (Debt) Net Cash Growth | -276.46 | -276.46 | -295.14 | -257.21 | -181.25 | -450.29 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -2.76 | -2.76 | -2.92 | -2.54 | -1.85 | -4.64 |
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Cash Flow Operating Cash Flow Growth | 88.43 | 88.43 | 107.64 | 15.55 | 35.45 | 70.92 |
Capital Expenditures CapEx Growth | -19.38 | -19.38 | -20.33 | -23.16 | -15.44 | -7.7 |
Free Cash Flow Free Cash Flow Growth | 69.05 | 69.05 | 87.3 | -7.61 | 20.02 | 63.22 |
Free Cash Flow Growth | - | -20.90% | - | - | -68.34% | 11.93% |
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Gross Margin | 51.23% | 51.23% | 56.16% | 58.31% | 56.87% | 57.72% |
Operating Margin | -7.62% | -7.62% | 14.45% | 8.46% | -2.25% | 19.02% |
Pretax Margin | -22.63% | -22.63% | 10.85% | 11.84% | -23.26% | 0.26% |
Profit Margin | -18.27% | -18.27% | 9.52% | 8.96% | -26.50% | -3.15% |
FCF Margin | 18.47% | 18.47% | 20.60% | -1.89% | 4.96% | 19.07% |
| Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
PE Ratio | - | - | 11.38 | 16.40 | - | - |
Forward PE | - | 4.79 | 14.09 | 12.21 | 22.67 | - |
P/FCF Ratio | 0.85 | 3.82 | 5.26 | - | 54.96 | 4.11 |
PS Ratio | 0.16 | 0.71 | 1.08 | 1.47 | 2.73 | 0.78 |